169 related articles for article (PubMed ID: 19098003)
41. The PI3K/AKT pathway promotes gefitinib resistance in mutant KRAS lung adenocarcinoma by a deacetylase-dependent mechanism.
Jeannot V; Busser B; Brambilla E; Wislez M; Robin B; Cadranel J; Coll JL; Hurbin A
Int J Cancer; 2014 Jun; 134(11):2560-71. PubMed ID: 24374738
[TBL] [Abstract][Full Text] [Related]
42. ErbB4 splice variants Cyt1 and Cyt2 differ by 16 amino acids and exert opposing effects on the mammary epithelium in vivo.
Muraoka-Cook RS; Sandahl MA; Strunk KE; Miraglia LC; Husted C; Hunter DM; Elenius K; Chodosh LA; Earp HS
Mol Cell Biol; 2009 Sep; 29(18):4935-48. PubMed ID: 19596786
[TBL] [Abstract][Full Text] [Related]
43. Deacetylase activity is required for STAT5-dependent GM-CSF functional activity in macrophages and differentiation to dendritic cells.
Sebastián C; Serra M; Yeramian A; Serrat N; Lloberas J; Celada A
J Immunol; 2008 May; 180(9):5898-906. PubMed ID: 18424709
[TBL] [Abstract][Full Text] [Related]
44. Shh/Ptch and EGF/ErbB cooperatively regulate branching morphogenesis of fetal mouse submandibular glands.
Mizukoshi K; Koyama N; Hayashi T; Zheng L; Matsuura S; Kashimata M
Dev Biol; 2016 Apr; 412(2):278-87. PubMed ID: 26930157
[TBL] [Abstract][Full Text] [Related]
45. Ventricular ErbB2/ErbB4 activation and downstream signaling in pacing-induced heart failure.
Doggen K; Ray L; Mathieu M; Mc Entee K; Lemmens K; De Keulenaer GW
J Mol Cell Cardiol; 2009 Jan; 46(1):33-8. PubMed ID: 19010331
[TBL] [Abstract][Full Text] [Related]
46. Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase/Akt.
Fukazawa R; Miller TA; Kuramochi Y; Frantz S; Kim YD; Marchionni MA; Kelly RA; Sawyer DB
J Mol Cell Cardiol; 2003 Dec; 35(12):1473-9. PubMed ID: 14654373
[TBL] [Abstract][Full Text] [Related]
47. System-wide investigation of ErbB4 reveals 19 sites of Tyr phosphorylation that are unusually selective in their recruitment properties.
Kaushansky A; Gordus A; Budnik BA; Lane WS; Rush J; MacBeath G
Chem Biol; 2008 Aug; 15(8):808-17. PubMed ID: 18721752
[TBL] [Abstract][Full Text] [Related]
48. Receptor tyrosine kinase ERBB4 mediates acquired resistance to ERBB2 inhibitors in breast cancer cells.
Canfield K; Li J; Wilkins OM; Morrison MM; Ung M; Wells W; Williams CR; Liby KT; Vullhorst D; Buonanno A; Hu H; Schiff R; Cook RS; Kurokawa M
Cell Cycle; 2015; 14(4):648-55. PubMed ID: 25590338
[TBL] [Abstract][Full Text] [Related]
49. Neuregulin-1β promotes glucose uptake via PI3K/Akt in neonatal rat cardiomyocytes.
Pentassuglia L; Heim P; Lebboukh S; Morandi C; Xu L; Brink M
Am J Physiol Endocrinol Metab; 2016 May; 310(9):E782-94. PubMed ID: 26979522
[TBL] [Abstract][Full Text] [Related]
50. Normal female sexual development requires neuregulin-erbB receptor signaling in hypothalamic astrocytes.
Prevot V; Rio C; Cho GJ; Lomniczi A; Heger S; Neville CM; Rosenthal NA; Ojeda SR; Corfas G
J Neurosci; 2003 Jan; 23(1):230-9. PubMed ID: 12514220
[TBL] [Abstract][Full Text] [Related]
51. Biphasic regulation of extracellular signal-regulated kinases by scalaradial, a secretory phospholipase A(2) inhibitor.
Xie Y; Yu Z; Liu L; Guo Y; Lou L
Cancer Biol Ther; 2006 Aug; 5(8):988-92. PubMed ID: 16760675
[TBL] [Abstract][Full Text] [Related]
52. Chemotherapy-induced epidermal growth factor receptor activation determines response to combined gefitinib/chemotherapy treatment in non-small cell lung cancer cells.
Van Schaeybroeck S; Kyula J; Kelly DM; Karaiskou-McCaul A; Stokesberry SA; Van Cutsem E; Longley DB; Johnston PG
Mol Cancer Ther; 2006 May; 5(5):1154-65. PubMed ID: 16731747
[TBL] [Abstract][Full Text] [Related]
53. Changes in ErbB2 (her-2/neu), ErbB3, and ErbB4 during growth, differentiation, and apoptosis of normal rat mammary epithelial cells.
Darcy KM; Zangani D; Wohlhueter AL; Huang RY; Vaughan MM; Russell JA; Ip MM
J Histochem Cytochem; 2000 Jan; 48(1):63-80. PubMed ID: 10653587
[TBL] [Abstract][Full Text] [Related]
54. ErbB4-neuregulin signaling modulates synapse development and dendritic arborization through distinct mechanisms.
Krivosheya D; Tapia L; Levinson JN; Huang K; Kang Y; Hines R; Ting AK; Craig AM; Mei L; Bamji SX; El-Husseini A
J Biol Chem; 2008 Nov; 283(47):32944-56. PubMed ID: 18819924
[TBL] [Abstract][Full Text] [Related]
55. Modulation of p53, ErbB1, ErbB2, and Raf-1 expression in lung cancer cells by depsipeptide FR901228.
Yu X; Guo ZS; Marcu MG; Neckers L; Nguyen DM; Chen GA; Schrump DS
J Natl Cancer Inst; 2002 Apr; 94(7):504-13. PubMed ID: 11929951
[TBL] [Abstract][Full Text] [Related]
56. An Unbiased Functional Genetics Screen Identifies Rare Activating ERBB4 Mutations.
Chakroborty D; Ojala VK; Knittle AM; Drexler J; Tamirat MZ; Ruzicka R; Bosch K; Woertl J; Schmittner S; Elo LL; Johnson MS; Kurppa KJ; Solca F; Elenius K
Cancer Res Commun; 2022 Jan; 2(1):10-27. PubMed ID: 36860695
[TBL] [Abstract][Full Text] [Related]
57. ErbB4 isoforms selectively regulate growth factor induced Madin-Darby canine kidney cell tubulogenesis.
Zeng F; Zhang MZ; Singh AB; Zent R; Harris RC
Mol Biol Cell; 2007 Nov; 18(11):4446-56. PubMed ID: 17761534
[TBL] [Abstract][Full Text] [Related]
58. ERBB4 promotes the proliferation of gastric cancer cells via the PI3K/Akt signaling pathway.
Xu J; Gong L; Qian Z; Song G; Liu J
Oncol Rep; 2018 Jun; 39(6):2892-2898. PubMed ID: 29620274
[TBL] [Abstract][Full Text] [Related]
59. ErbB2 and ErbB4 Cbl binding sites can functionally replace the ErbB1 Cbl binding site.
Jansen SM; Sleumer LS; Damen E; Meijer IM; van Zoelen EJ; van Leeuwen JE
Cell Signal; 2009 May; 21(5):810-8. PubMed ID: 19263517
[TBL] [Abstract][Full Text] [Related]
60. Role for tyrosine phosphorylation of SUV39H1 histone methyltransferase in enhanced trimethylation of histone H3K9 via neuregulin-1/ErbB4 nuclear signaling.
Nakajo H; Ishibashi K; Aoyama K; Kubota S; Hasegawa H; Yamaguchi N; Yamaguchi N
Biochem Biophys Res Commun; 2019 Apr; 511(4):765-771. PubMed ID: 30833073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
